SCHEMBL4725543

SCHEMBL4725543

CCn1c(=NN=c2sc3ccccc3n2CCS(=O)(=O)O)sc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
TSHR P16473 2/20 0.49
MAPK1 P28482 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
KCNQ3 O43525 1/20 0.47
KCNQ2 O43526 1/20 0.47
CNR1 P21554 4/20 0.43
CNR2 P34972 4/20 0.43
KMT2A Q03164 4/20 0.41
LMNA P02545 2/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
MAPT P10636 4/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
POLB P06746 1/20 0.40
MEN1 O00255 2/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL8555602 0.99 ALDH1A1 (0.48) ALDH1A1TSHRMAPK1NPSR1KCNQ3
SCHEMBL5174967 0.93 LMNA (0.43) ALDH1A1TSHRMAPK1NPSR1KCNQ3
Ammonia Solution, Strong SCHEMBL886874 0.92 LMNA (0.42) ALDH1A1TSHRMAPK1NPSR1KCNQ3
Sulfuric Acid SCHEMBL2532781 0.89 TSHR (0.55) ALDH1A1TSHRMAPK1NPSR1KCNQ3
Sulfuric Acid SCHEMBL6515066 0.89 TSHR (0.55) ALDH1A1TSHRMAPK1NPSR1KCNQ3
SCHEMBL4623996 0.83 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1NPSR1KCNQ3
SCHEMBL29387616 0.83 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1NPSR1KCNQ3
SCHEMBL893600 0.83 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1NPSR1KCNQ3
Phosphoric Acid SCHEMBL6538345 0.81 TSHR (0.55) ALDH1A1TSHRMAPK1NPSR1KCNQ3
SCHEMBL18785100 0.80 ALDH1A1 (0.47) ALDH1A1TSHRMAPK1NPSR1KCNQ3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1585812-B1 MULTI-ANTIGENIC ALPHAVIRUS REPLICON PARTICLES AND METHODS ALPHAVAX INC (US) 2017-01-18 EP disclosed
US-8617533-B2 Multi-antigenic alphavirus replicon particles and methods ALPHAVAX, INC. (US) 2013-12-31 US disclosed
US-20080213309-A1 MULTI-ANTIGENIC ALPHAVIRUS REPLICON PARTICLES AND METHODS ALPHVAX, INC. (US) 2008-09-04 US disclosed
WO-2008015535-A2 COMPOSITION WITH IMPROVED ANTIOXIDANT AND ANTIGLYCATING ACTIVITY DIFASS S.A. (SM) 2008-02-07 WO disclosed
EP-1585812-A4 MULTI-ANTIGENIC ALPHAVIRUS REPLICON PARTICLES AND METHODS ALPHAVAX INC (US) 2007-05-02 EP disclosed
EP-1585812-A2 MULTI-ANTIGENIC ALPHAVIRUS REPLICON PARTICLES AND METHODS Alphavax, Inc. (US) 2005-10-19 EP disclosed
US-20040208848-A1 Multi-antigenic alphavirus replicon particles and methods ALPHAVAX, INC. 2004-10-21 US disclosed
WO-2004055166-A2 MULTI-ANTIGENIC ALPHAVIRUS REPLICON PARTICLES AND METHODS ALPHAVAX, INC. (US) 2004-07-01 WO disclosed